CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Income Tax Expense Over TimeContracting
Percentile Rank75
5Y CAGR-55.7%
Studio
Year-over-Year Change

Income taxes paid or accrued

5Y CAGR
-55.7%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$237000.00+5.8%
2024$224000.00-94.2%
2023$3.89M-
2022$0.00-
2021$0.00-100.0%
2020$13.91M+3357.8%
2019$-427000.00-103.0%
2018$14.30M+2888.1%
2017$-513000.00-2600.0%
2016$-19000.00-